Angina, Stable

• 

  Subject Areas on Research

  • 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. 
  • A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study. 
  • Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry. 
  • Antianginal therapy before percutaneous coronary intervention. 
  • BARI 2D: A Reanalysis Focusing on Cardiovascular Events. 
  • Benefits and risks of P2Y12 inhibitor preloading in patients with acute coronary syndrome and stable angina. 
  • CLINICAL PRACTICE. Chronic Stable Angina. 
  • Chronic Stable Angina. 
  • Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFR(CT): outcome and resource impacts study. 
  • Comparison of International Guidelines for Assessment of Suspected Stable Angina: Insights From the PROMISE and SCOT-HEART. 
  • Controversies in Diagnostic Imaging of Patients With Suspected Stable and Acute Chest Pain Syndromes. 
  • Effects of Exercise Training With and Without Ranolazine on Peak Oxygen Consumption, Daily Physical Activity, and Quality of Life in Patients With Chronic Stable Angina Pectoris. 
  • Estimating the real-world performance of the PROMISE minimal-risk tool. 
  • Extended-release ranolazine: critical evaluation of its use in stable angina. 
  • Fractional Flow Reserve Derived from Computed Tomography Coronary Angiography in the Assessment and Management of Stable Chest Pain: Rationale and Design of the FORECAST Trial. 
  • Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial. 
  • Identification of patients with stable chest pain deriving minimal value from coronary computed tomography angiography: An external validation of the PROMISE minimal-risk tool. 
  • Left Ventricular Intramyocardial Fat Detected on Cardiac Computed Tomography in Patients With Stable Chest Pain. 
  • Patient selection for diagnostic coronary angiography and hospital-level percutaneous coronary intervention appropriateness: insights from the National Cardiovascular Data Registry. 
  • Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry. 
  • Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice. 
  • Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes. 
  • Same-day discharge among patients undergoing elective PCI: Insights from the VA CART Program. 
  • Sham trials: benefits and risks for cardiovascular research and patients. 
  • Single-Molecule hsTnI and Short-Term Risk in Stable Patients With Chest Pain. 
  • The External Validity of Prediction Models for the Diagnosis of Obstructive Coronary Artery Disease in Patients With Stable Chest Pain: Insights From the PROMISE Trial. 
  • The theory and practice of imaging outcomes research.